Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer
Clinical trial NCT01276041 · COMPLETED
Trial details
- NCT number
- NCT01276041
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-05
- Primary completion
- 2019-08-07
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.